![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Familial Hyperinsulinism - 19 Studies Found
Completed |
: A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism : Congenital Hyperinsulinism : 2015-10-26 :
|
Recruiting |
: Fluorodopa F 18 in Congenital Hyperinsulinism : Congenital Hyperinsulinism : 2013-12-20 : Drug: Fluorodopa F 18 A dose of Fluorodopa F 18, 3-6 MBq/Kg (0.08-0.16 mCi/kg), will be injected intrave |
Recruiting |
: Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy : Congenital Hyperinsulinism : 2010-02-17 : Drug: Lanreotide autogel The dose of Lan-ATG will be calculated according to the surface area of the pat |
Completed |
: Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism : Congenital Hyperinsulinism : 2007-12-10 :
|
Completed |
: Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism : Non-focal Congenital Hyperinsulinism : 2014-03-28 : Procedure: restrictive pancreatic resection Restrictive, spleen-preserving resection of the pancreatic t |
Recruiting |
: CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism : Congenital Hyperinsulinism : 2016-10-14 :
|
Completed |
: Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity : Congenital Hyperinsulinism : 2009-05-08 :
|
Recruiting |
: Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia : Congenital Hyperinsulinism : 2009-02-02 :
|
Completed |
: Sandostatine® LP and Hyperinsulinism : Congenital Hyperinsulinism : 2009-09-29 : Drug: Sandostatine LP Intramuscular injection of Sandostatine LP, once per month Dosage : 10 mg, 20 mg, |
Available |
: Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia : Congenital Hyperinsulinism : 2016-07-13 : Drug: Pasireotide Other Names:
|